Research by Quebec-based scientists will be used to help in the development of new treatments for serious genetic bone diseases.
The study will support drug development for conditions such as osteoporosis, which often develop later in life due to bone density issues and can lead to spinal injury.
Dr Marc McKee, of McGill's Faculty of Dentistry, is currently examining the reasons why calcium-phosphate minerals fail to crystallise properly to form strong bones and teeth.
The research applies especially to child patients, who never mineralised their skeletons properly to begin with.
Dr McKee said: "Montreal is a world-leader in the biomineralisation field, having attracted some of the top international specialists.
"We are opening doors to the development of treatments for all kinds of problems related to the crystallisation of minerals in the body, including seemingly unrelated areas such [as] cardiovascular diseases."
Research published in the Journal of Bone & Joint Surgery in November indicated that aggressive management of osteoporosis could reduce the hip fracture rate in the US by 25 per cent.
News by Serious Law. Expert legal assistance for those affected by spinal injury